Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf-based immunosuppression regimens and renal function after liver transplantation
2008-002231-32Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus, mycophenolate mofetil and basiliximab in liver transplant (3 arms), sponsored by Astellas Pharma. Started Jan 2009; status: completed.
02
Drugs
tacrolimusmycophenolate mofetilbasiliximab
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2008-002231-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002231-32.